文献速递细菌感染、耐药与抗菌药物

难治性耐药对革兰阴性菌血流感染死亡率的影响:全国监测数据的回顾性分析

Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该回顾性研究基于全国监测数据库,分析1167例单一革兰阴性菌血流感染,其中147例(12.6%)为难治性耐药(DTR)。多因素模型显示仅DTR与30天院内死亡显著相关(aOR 3.58,95%CI 1.27-10.19),倾向评分匹配队列中同样显著(aOR 3.48,95%CI 1.82-6.79)。

要点

  • DTR定义为对所有测试的β-内酰胺类和氟喹诺酮类不敏感。
  • DTR感染粗死亡率为50.3%,多因素分析仅DTR与死亡独立相关。
  • DTR菌株以不动杆菌属(79.6%)和铜绿假单胞菌(17.7%)为主。

核心结论

  • 在革兰阴性菌血流感染患者中,DTR与比其他耐药类别更高的死亡率相关。
  • DTR可能有助于监测和预后评估。

研究设计与样本

  • 回顾性研究,数据来自全国监测数据库,纳入1167例单一革兰阴性菌血流感染,其中147例(12.6%)为DTR。
  • 比较DTR与非DTR的碳青霉烯耐药及超广谱头孢菌素耐药分离株感染的患者特征和死亡率。
  • 采用多因素模型和倾向评分匹配队列分析30天院内死亡调整比值比(aOR)。

主要发现

  • DTR感染与既往抗生素使用、医疗接触、呼吸机使用和下呼吸道感染相关。
  • DTR血流感染粗死亡率为50.3%。
  • 多因素模型显示仅DTR与死亡率显著相关(aOR 3.58,95%CI 1.27-10.19)。
  • 倾向评分匹配队列中DTR仍是死亡的显著预测因素(aOR 3.48,95%CI 1.82-6.79)。
  • DTR分离株主要来自不动杆菌属(79.6%)和铜绿假单胞菌(17.7%)。

关键数值与推荐

  • DTR定义为对所有测试的β-内酰胺类和氟喹诺酮类不敏感。
  • 耐药类别定义采用美国CDC定义。

临床怎么用

  • 临床中可将DTR作为革兰阴性菌血流感染死亡风险分层和预后评估的指标。
  • 对既往抗生素使用、医疗接触、呼吸机使用及下呼吸道感染患者应警惕DTR感染。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinically relevant categorization of antimicrobial resistance is critical to mitigating the threat it poses. Difficult-to-treat resistance (DTR) is a recently proposed category defined as nonsusceptibility to all first-line antibiotic agents. METHODS: A retrospective study was conducted with nonduplicate cases of gram-negative bloodstream infection (GNBSI) caused by 4 major taxa (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter species) identified from a nationwide surveillance database. DTR was defined as nonsusceptibility to all the β-lactams and fluoroquinolones tested. Patient characteristics and mortality were compared between DTR GNBSI and GNBSI caused by carbapenem-resistant but not DTR and extended-spectrum cephalosporin-resistant but not DTR isolates using Centers for Disease Control and Prevention definitions. Adjusted odds ratios (aORs) for 30-day in-hospital mortality were examined for DTR in overall and in propensity score-matched cohorts. RESULTS: A total of 1167 episodes of monomicrobial GNBSI were identified, and 147 (12.6%) of the isolates were DTR. The majority of DTR isolates were Acinetobacter species (79.6%) and P. aeruginosa (17.7%). DTR infections were associated with previous antibiotic use, healthcare contact, ventilator use, and lower respiratory tract infection. Crude mortality for GNBSI caused by DTR was 50.3%. A multivariable model showed that only DTR, but not other categories, was significantly associated with mortality (adjusted odds ratio [aOR], 3.58 [95% confidence interval {CI}, 1.27-10.19]). DTR was also a significant predictor for mortality in the analysis of propensity score-matched cohorts (aOR, 3.48 [95% CI, 1.82-6.79]). CONCLUSIONS: In patients with GNBSI, DTR was associated with higher mortality than those in other resistance categories. Our findings suggest that DTR could be useful for surveillance and prognostication.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Huh K, Chung DR, Ha YE, et al. Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data. Clin Infect Dis. 2020. PMID: 31994704. doi:10.1093/cid/ciaa084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。